[1] |
Xiao B, Jing C, Kelly G, et al. Specificity and mechanism of the histone methyltransferase Pr-Set7[J]. Genes Dev, 2005, 19(12): 14 44-54.
|
[2] |
Couture JF, Collazo E, Brunzelle JS, et al. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase[J]. Genes Dev, 2005, 19(12): 1455-65.
|
[3] |
Fang J, Feng Q, Ketel CS, et al. Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20 -specific methyltransferase[J]. Curr Biol, 2002, 12(13): 1086-99.
|
[4] |
Abbas T, Shibata E, Park J, et al. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/ Set8 for degradation[J]. Mol Cell, 2010, 40(1): 9-21.
|
[5] |
Liang XQ, Du YP, Wang DL, et al. The biological functions of lysine methyltransferase PR-SET7[J]. Yi Chuan, 2013, 35(3): 24 1-54.
|
[6] |
Wu S, Wang W, Kong X, et al. Dynamic regulation of the PRSet7 histone methyltransferase is required for normal cell cycle progression[J]. Genes Dev, 2010, 24(22): 2531-42.
|
[7] |
Oda H, Okamoto I, Murphy N, et al. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development[J]. Mol Cell Biol, 2009, 29 (8): 2278-95.
|
[8] |
Houston SI, McManus KJ, Adams MM, et al. Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability[J]. J Biol Chem, 20 08, 283(28): 19478-88.
|
[9] |
Wu S, Rice JC. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase[J]. Cell Cycle, 2011, 10(1): 68-72.
|
[10] |
Le e J , Zh o u P. SETt i n g t h e c l o c k f o r h i s t o n e H4 monomethylation[J]. Mol Cell, 2010, 40(3): 345-6.
|
[11] |
Yin Y,Yu VC, Zhu G, et al. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail[J]. Cell Cycle, 2008, 7(10): 14 23-32.
|
[12] |
Sakaguchi A, Steward R. Aberrant monomethylation of histone H4 lysine 20 activates the DNA damage checkpoint in Drosophila melanogaster[J]. J Cell Biol, 2007, 176(2): 155-62.
|
[13] |
Davey CA, Sargent DF, Luger K, et al. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution[J]. J Mol Biol, 2002, 319(5): 1097-113.
|
[14] |
Dorigo B, Schalch T, Bystricky K, et al. Chromatin ?ber folding: requirement for the histone H4 N-terminal tail[J]. J Mol Biol, 20 03, 327(1): 85-96.
|
[15] |
Trojer P, Li G, Sims RJ 3rd, et al. L3MBTL1, a histonemethylation- dependent chromatin lock[J]. Cell, 2007, 129(5): 91 5-28.
|
[16] |
Scharf AN, Meier K, Seitz V, et al. Monomethylation of lysine 20 on histone H4 facilitates chromatin maturation[J]. Mol Cell Biol, 20 09, 29(1): 57-67.
|
[17] |
Lu X, Simon MD, Chodaparambil JV, et al. The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure[J]. Nat Struct Mol Biol, 2008, 15(10): 1122-4.
|
[18] |
Li Z, Nie F, Wang S, et al. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation[J]. Proc Natl Acad Sci U S A, 2011, 108(8): 3116-23.
|
[19] |
Yang F, Sun L, Li Q, et al. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities[J]. EMBO J, 2012, 31(1): 110-23.
|
[20] |
Shi X, Kachirskaia I, Yamaguchi H, et al. Modulation of p53 function by SET8-mediated methylation at lysine 382[J]. Mol Cell, 2007, 27(4): 636-46.
|
[21] |
Takawa M, Cho HS, Hayami S, et al. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression[J]. Cancer Res, 2012, 72(13): 3217-27.
|
[22] |
Song F, Zheng H, Liu B, et al. An miR-502-binding site singlenucleotide polymorphism in the 3’-untranslated region of the SET8 gene is associated with early age of breast cancer onset[J]. Clin Cancer Res, 2009, 15(19): 6292-300.
|
[23] |
Colaluca IN, Tosoni D, Nuciforo P, et al. NUMB controls p53 tumour suppressor activity[J]. Nature, 2008, 451(7174): 76-80.
|
[24] |
Dhami GK, Liu H, Galka M, et al. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis[J]. Mol Cell, 20 13, 50(4): 565-76.
|
[25] |
Guo Z, Wu C, Wang X, et al. A polymorphism at the miR-502 binding site in the 3’-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome[J]. Int J Cancer, 2012, 131(6): 1318-22.
|
[26] |
Fabbri M, Croce CM, Calin GA. MicroRNAs[J]. Cancer J, 2008, 14 (1): 1-6.
|
[27] |
Yang S, Guo H, Wei B, et al. Association of miR-502-binding site single nucleotide polymorphism in the 3’-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population[J]. Acta Biochim Biophys Sin(Shanghai), 2014, 46(2): 149-54.
|
[28] |
Xu J, Yin Z, Gao W, et al. Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population[J]. PLoS One, 2013, 8( 10): e77024.
|
[29] |
Ding C, Li R, Peng J, et al. A polymorphism at the miR-502 binding site in the 3’ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer[J]. Exp Ther Med, 2012, 3(4): 689-92.
|
[30] |
Wang C, Guo Z, Wu C, et al. A polymorphism at the miR-502 binding site in the 3’ untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer[J]. Cancer Genet, 2012, 205(7-8): 373-6.
|